A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

December 6, 2019

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions

Health Participants

Interventions

DRUG

BMS-986209

Specified Dose on Specified Days

OTHER

BMS-986209 Placebo

Specified Dose on Specified Days

DRUG

Itraconazole

Specified Dose on Specified Days

DRUG

Diltiazem

Specified Dose on Specified Days

Trial Locations (1)

PPD Development, LP, Austin